Science & Enterprise subscription

Follow us on Twitter

  • Symptom checker K Health raises $48M
    about 5 hours ago
  • This makes me feel better ... Pence Will Control All Coronavirus Messaging From Health Officials
    about 24 hours ago
    about 24 hours ago
  • Takeda acquires PvP Biologics for $330M following Phase I celiac disease study results
    about 1 day ago
  • Raises $462M With Toyota In The Driver’s Seat via @crunchbasenews
    about 2 days ago

Please share Science & Enterprise

23andMe Offering Genetic Analysis Service for Researchers


DNA collection kit

23andMe DNA collection kit (23andMe Inc.)

13 July 2016. The personal genetics company 23andMe is offering a new analytical service for researchers that determines genotypes, or genetic variations, of individuals taking part in their studies. The Mountain View, California enterprise says its genotyping service for researchers includes collecting specimens and returning results of the analysis to individual study participants.

The new service, says the company, aims to simplify the process of collecting genetic data in research studies. Researchers, with studies approved by institutional review boards that govern research with human subjects, can employ the 23andMe service to collect saliva specimens, extract DNA, determine genetic variations through tests and reagents, return data and project reports to investigators, and return personal analytical reports to study participants.

The company says the genotyping service can also be combined with its iPhone app for researchers wanting to use mobile devices for data collection. As reported in Science & Enterprise, 23andMe unveiled in March 2016 a software module for Apple’s ResearchKit platform that makes it possible to add genetics data to iPhone apps used in medical research. ResearchKit is an open-source framework for collecting medical data with surveys or sensors connected to iPhones.

The 23andMe genotyping service is being pilot tested with researchers at University of California in San Diego, University of Southern California, Washington University in St. Louis, and McMaster University in Hamilton, Ontario, Canada. The company says pilot tests include research on smoking cessation, cognitive impairment in glioma patients, as well as addictions and psychiatric disorders.

The company says the genotyping service could make it easier for investigators to recruit participants by making it simple for individuals to collect saliva samples at home and return them to 23andMe for analysis. Participants would also receive their individual results collected for the research study as well as be eligible for 23andMe reports on ancestry, wellness, unique traits, and inherited conditions.

“Typically, research studies don’t return any data to the participants,” says 23andMe vice-president Ruby Gadelrab in a company statement. “We’ve enabled researchers to give results back to participants in the form of the 23andMe experience, which we believe is a huge advantage in recruiting.”

Read more:

*     *     *

Please share Science & Enterprise ...

Comments are closed.